LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike

Characterizing Oligonucleotides

Guides | 2023 | WatersInstrumentation
Consumables, LC columns, Standards and chemicals
Industries
Pharma & Biopharma
Manufacturer
Waters

Summary

Significance of the Topic


Oligonucleotide-based drugs have gained momentum due to their ability to treat genetic and hard-to-address diseases. Precise characterization ensures correct sequence identity, purity, and modification integrity critical for safety and efficacy.

Objectives and Article Overview


This guide reviews high-performance chromatographic techniques for thorough analysis of synthetic oligonucleotides. It outlines methods for confirming identity, assessing purity, detecting modifications, and comparing various LC approaches including IP-RPLC, HILIC, AEX, and SEC.

Methodology


Four complementary chromatographic modes are presented:
  • Ion-Pairing Reversed-Phase LC (IP-RPLC): Uses triethylamine or alternative alkylamines with C18 stationary phases (130Å and 300Å) for accurate mass confirmation and impurity profiling.
  • Anion Exchange (AEX): Exploits charge differences through weak and strong exchangers (Gen-Pak FAX, Protein-Pak HiRes Q) with tunable pH and gradient conditions.
  • Hydrophilic Interaction LC (HILIC): Leverages BEH amide phases and ammonium acetate mobile phases for ion-pairing free separations and improved LC–MS performance.
  • Size Exclusion Chromatography (SEC): Enables native separation and desalting of oligonucleotides and duplex analysis using 100–300Å columns coupled to UV–MS.

Used Instrumentation


  • Waters ACQUITY Premier Oligonucleotide BEH C18 Columns (130Å, 300Å)
  • Waters XBridge Premier BEH Amide and ACQUITY Premier BEH Amide Columns (HILIC)
  • Gen-Pak FAX and Protein-Pak HiRes Q Anion Exchange Columns
  • ACQUITY Premier and XBridge Protein SEC Columns for native LC–UV–MS

Main Results and Discussion


  • IP-RPLC delivered robust separation of phosphorothioated siRNA and related impurities, with MaxPeak HPS surfaces enhancing peak shape and reproducibility.
  • AEX provided distinct selectivity for charged oligonucleotide species, allowing control over retention via pH and ion-pairing additives.
  • HILIC offered a non–ion-pair workflow with high efficiency, benefiting MS compatibility and resolution of modified sequences.
  • SEC demonstrated potential for rapid desalting and duplex integrity assessment, separating 5–150 mer oligonucleotides under native conditions.

Benefits and Practical Applications


  • Comprehensive identity confirmation through combined retention and accurate mass analysis.
  • Purity assessment to detect n-1 shortmers, oxidation, deamination, and depurination products.
  • Workflow flexibility to match analytical goals, from routine QC to advanced structural characterization.
  • Compatibility with mass spectrometry for detailed fragmentation mapping and modification localization.

Future Trends and Opportunities


Advances in stationary phase design and surface chemistries are expected to further improve separation performance and reduce adsorption. Integration of native LC–MS workflows and automated microfluidic platforms may enable faster, high-throughput characterization. Emerging chromatographic materials and AI-driven method optimization promise streamlined development for next-generation oligonucleotide therapeutics.

Conclusion


A strategic combination of IP-RPLC, AEX, HILIC, and SEC techniques provides a complete toolkit for synthetic oligonucleotide analysis. By leveraging specialized columns and optimized conditions, laboratories can achieve reliable identity, purity, and structural insights essential for therapeutic development and quality control.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
Characterizing LNP mRNA
Characterizing LNP mRNA
2024|Waters|Guides
CONSUMABLES GUIDE BOOK Characterizing LNP mRNA LC tools for purity, identity, integrity and concentration determining measurements A Changing Industry mRNA based medicine helped address the COVID-19 pandemic. The viability of using an mRNA construct as a human drug substance has…
Key words
lipid, lipidmrna, mrnarplc, rplclnp, lnpvanguard, vanguardanion, anionbook, bookaex, aexcolumn, columndiameter, diameterfit, fitconsumables, consumablesguide, guideoligo, oligocsh
Characterizing AAVs
Characterizing AAVs
2023|Waters|Guides
CONSUMABLES GUIDE BOOK Characterizing AAVs Chromatographic methods to measure heterogeneity and critical quality attributes CONSUMABLES GUIDE BOOK A Changing Industry Attribute Testing The advent of FDA approved gene therapies brings An AAV vectored therapy contains multiple types of biomolecules compromised…
Key words
aav, aavprotein, proteintransgene, transgenecapsid, capsidbook, bookpak, pakaex, aexencapsidation, encapsidationgenome, genomecolumn, columnpotency, potencyrplc, rplcdiameter, diameterpeptide, peptideconsumables
Quantifying Oligonucleotides (CONSUMABLES GUIDE BOOK)
[ CONSUMABLES GUIDE BOOK ] Quantifying Oligonucleotides Sample Extraction and LC Tools for Reliable LC-MS Quantitation of Oligonucleotides A Changing Industry There has been a resurgence in synthetic oligonucleotide therapeutics in the past decade, as seen with burgeoning pipelines across…
Key words
oligoworks, oligoworksspe, speoligonucleotides, oligonucleotidesvanguard, vanguardoligonucleotide, oligonucleotidecolumn, columnpremier, premierbook, bookformat, formatfit, fitconjugated, conjugatedmaxpeak, maxpeakextraction, extractionbioanalytical, bioanalyticaldiameter
Separation Solutions to Accelerate Next Generation Gene Therapy Development
Separation Solutions to Accelerate Next Generation Gene Therapy Development The therapeutics you are working on are cutting edge, complex and ultimately life-changing. Waters is here to help partner with you from bench to clinic through these challenges. COMMON ANALYTICAL QUESTIONS…
Key words
aex, aexpremier, premiercqa, cqainfo, infoacquity, acquityaav, aavreversed, reversedionhance, ionhancedfa, dfacapsid, capsidprotein, proteinbeh, behres, resordering, orderingtherapy
Other projects
GCMS
ICPMS
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike